Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 c-Ki-ras amplification in human lung cancer.

Literature DB >> 3006736

c-Ki-ras amplification in human lung cancer.

J Heighway, P S Hasleton.

Abstract

Entities: Disease Gene Species

Mesh：

Substances：

Year: 1986 PMID： 3006736 PMCID： PMC2001323 DOI： 10.1038/bjc.1986.47

Source DB: PubMed Journal: Br J Cancer ISSN： 0007-0920 Impact factor: 7.640

× No keyword cloud information.

13 in total

1. Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors: E M Southern
Journal: J Mol Biol Date: 1975-11-05 Impact factor: 5.469

2. Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I.

Authors: P W Rigby; M Dieckmann; C Rhodes; P Berg
Journal: J Mol Biol Date: 1977-06-15 Impact factor: 5.469

3. Analysis of human Y-chromosome-specific reiterated DNA in chromosome variants.

Authors: L M Kunkel; K D Smith; S H Boyer; D S Borgaonkar; S S Wachtel; O J Miller; W R Breg; H W Jones; J M Rary
Journal: Proc Natl Acad Sci U S A Date: 1977-03 Impact factor: 11.205

4. The p21 src genes of Harvey and Kirsten sarcoma viruses originate from divergent members of a family of normal vertebrate genes.

Authors: R W Ellis; D Defeo; T Y Shih; M A Gonda; H A Young; N Tsuchida; D R Lowy; E M Scolnick
Journal: Nature Date: 1981-08-06 Impact factor: 49.962

5. Unique aspects of the interactions of retroviruses with vertebrate cells: C. P. Rhoads memorial lecture.

Authors: S A Aaronson
Journal: Cancer Res Date: 1983-01 Impact factor: 12.701

6. Karyotypic characterization of established cell lines and short-term cultures of human lung cancers.

Authors: L Zech; J Bergh; K Nilsson
Journal: Cancer Genet Cytogenet Date: 1985-02-15

7. Characterization of a human colon/lung carcinoma oncogene.

Authors: M S McCoy; J J Toole; J M Cunningham; E H Chang; D R Lowy; R A Weinberg
Journal: Nature Date: 1983-03-03 Impact factor: 49.962

8. Amplification and expression of the c-myc oncogene in human lung cancer cell lines.

Authors: C D Little; M M Nau; D N Carney; A F Gazdar; J D Minna
Journal: Nature Date: 1983 Nov 10-16 Impact factor: 49.962

9. Malignant activation of a K-ras oncogene in lung carcinoma but not in normal tissue of the same patient.

Authors: E Santos; D Martin-Zanca; E P Reddy; M A Pierotti; G Della Porta; M Barbacid
Journal: Science Date: 1984-02-17 Impact factor: 47.728

10. Amplification of the c-myb oncogene in a case of human acute myelogenous leukemia.

Authors: P G Pelicci; L Lanfrancone; M D Brathwaite; S R Wolman; R Dalla-Favera
Journal: Science Date: 1984-06-08 Impact factor: 47.728

9 in total

1. KRAS and HRAS mutations confer resistance to MET targeting in preclinical models of MET-expressing tumor cells.

Authors: Dominic Leiser; Michaela Medová; Kei Mikami; Lluís Nisa; Deborah Stroka; Andree Blaukat; Friedhelm Bladt; Daniel M Aebersold; Yitzhak Zimmer
Journal: Mol Oncol Date: 2015-04-14 Impact factor: 6.603

2. Anonymous genomic fragment co-amplified with c-Ki-ras 2 detects frequent polymorphism (pK42).

Authors: J Heighway; A H Geurts van Kessel
Journal: Nucleic Acids Res Date: 1986-11-11 Impact factor: 16.971

3. Isolation of a human genomic fragment, co-amplified with c-Ki-ras, that affects plasmid supercoiling in E. coli.

Authors: J Heighway; A H Geurts van Kessel
Journal: Nucleic Acids Res Date: 1987-04-24 Impact factor: 16.971

4. Ras in cancer and developmental diseases.

Authors: Alberto Fernández-Medarde; Eugenio Santos
Journal: Genes Cancer Date: 2011-03

5. Human lung epithelial cells progressed to malignancy through specific oncogenic manipulations.

Authors: Mitsuo Sato; Jill E Larsen; Woochang Lee; Han Sun; David S Shames; Maithili P Dalvi; Ruben D Ramirez; Hao Tang; John Michael DiMaio; Boning Gao; Yang Xie; Ignacio I Wistuba; Adi F Gazdar; Jerry W Shay; John D Minna
Journal: Mol Cancer Res Date: 2013-02-28 Impact factor: 5.852

6. Analysis of p53, K-ras-2, and C-raf-1 in pulmonary neuroendocrine tumors. Correlation with histological subtype and clinical outcome.

Authors: R M Przygodzki; S D Finkelstein; J C Langer; P A Swalsky; N Fishback; A Bakker; D G Guinee; M Koss; W D Travis
Journal: Am J Pathol Date: 1996-05 Impact factor: 4.307